Abstract
Introduction Adolescent e-cigarette use is a developing phenomenon. Greater surveillance of underage use is necessary to inform e-cigarette policy and mitigate adolescent e-cigarette use. Accurate prevalence estimates for adolescent e-cigarette use are provided by large national surveys. However, these surveys are costly and provide only annual estimates. To obtain more affordable estimates faster and more frequently, novel methods are required.
Methods Online search term popularity data were taken from Google Trends. Interest in the search terms ‘vapes’, ‘vape’, and ‘vape pen’ were followed monthly from January 2011 to November 2020. Time-lagged zero-normalized cross-correlations were performed between the Google data and current (past 30 day) high-school e-cigarette use prevalence estimates from the National Youth Tobacco Survey (NYTS). The search interest data were then calibrated to the NYTS data to estimate adolescent e-cigarette use prevalence using online searches.
Results Maximum correlation coefficients of 0.979 for ‘vapes’ and 0.938 for ‘vape’ were obtained when search interest lagged use prevalence by one month, and 0.970 for ‘vape pen’ when the lag was two months (p < 0.0001 for all). Calibrating the search term data to NYTS provided a high-school current e-cigarette use prevalence estimate of 11.3–16.5% for November 2020, suggesting adolescent use of e-cigarettes has continued to decline since the NYTS estimate of 19.6% for January–March 2020.
Conclusion Online search trend data may provide reasonably reliable and more frequent estimates of adolescent e-cigarette use prevalence at substantially lower costs than traditional surveys. Such additional data may help in developing adolescent e-cigarette use prevention efforts.
Competing Interest Statement
In 2020, Floe Foxon became a consultant to PinneyAssociates, Inc. PinneyAssociates provides consulting services on tobacco harm reduction on an exclusive basis to Juul Labs, Inc. In recent years, PinneyAssociates has consulted for British American Tobacco and Reynolds American Inc and subsidiaries on tobacco harm reduction. Juul Labs, Inc. did not sponsor this paper or participate in the design, study execution, data analysis, writing, or publication.
Funding Statement
This work was not supported by any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Twitter: @FloeFoxon
Data Availability
NYTS data are publicly available from the US Centers for Disease Control and Prevention. Google Trends data are publicly available from Google.
https://www.cdc.gov/tobacco/data_statistics/surveys/nyts/data/index.html